draflazine

RN = 120770-34-5 N1 = 1-Piperazineacetamide, 2-(aminocarbonyl)-N-(4-amino-2,6-dichlorophenyl)-4-(5,5-bis(4-fluorophenyl)pentyl)-
SY = 2-aminocarbonyl-N-(4-amino-2,6-dichlorophenyl)-4-(5,5-bis(4-fluorophenyl)-pentyl)-1-piperazineacetamide
SY = R 75 231
SY = R 75231
SY = R 88 016
SY = R 88016
SY = R-75231
SY = R-88016
SY = R75231
HM = *Piperazines
SO = Ann Thorac Surg 1991;52(6):1300
TH = USAN (1994)
PA = Cardiotonic Agents
PA = Platelet Aggregation Inhibitors
FR = 47
NO = a nucleoside transport inhibitor; has cardioprotective effect; draflazine is the (-)-enantiomer; R 88016 is the (+)-enantiomer
DA = 19920124
MR = 20010711
UI = C072040

<< DRAF1 transcription factor
|
dragmacidin A >>
Copyright-Infos
(Filename: http://www.bfarm.info/dr/draflazine.htm)